Free Trial
NASDAQ:EXPO

Exponent (EXPO) Stock Price, News & Analysis

$94.25
-0.19 (-0.20%)
(As of 07/5/2024 08:52 PM ET)
Today's Range
$93.56
$94.65
50-Day Range
$91.85
$97.13
52-Week Range
$64.61
$102.72
Volume
106,000 shs
Average Volume
278,834 shs
Market Capitalization
$4.78 billion
P/E Ratio
47.60
Dividend Yield
1.19%
Price Target
$100.00

Exponent MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
6.1% Upside
$100.00 Price Target
Short Interest
Bearish
2.91% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
0.68mentions of Exponent in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$4.73 M Sold Last Quarter
Proj. Earnings Growth
6.77%
From $1.92 to $2.05 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.69 out of 5 stars

Business Services Sector

203rd out of 293 stocks

Management Consulting Services Industry

12th out of 14 stocks

EXPO stock logo

About Exponent Stock (NASDAQ:EXPO)

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.

EXPO Stock Price History

EXPO Stock News Headlines

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”
Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.
Exponent, Inc. (NASDAQ:EXPO) Short Interest Update
Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”
Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.
See More Headlines
Receive EXPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exponent and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/25/2024
Ex-Dividend for 6/21 Dividend
6/07/2024
Dividend Payable
6/21/2024
Today
7/07/2024
Next Earnings (Confirmed)
7/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
Research & Consulting Services
Current Symbol
NASDAQ:EXPO
CUSIP
30214U10
Employees
1,320
Year Founded
1967

Price Target and Rating

Average Stock Price Target
$100.00
High Stock Price Target
$100.00
Low Stock Price Target
$100.00
Potential Upside/Downside
+6.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$100.34 million
Pretax Margin
26.00%

Debt

Sales & Book Value

Annual Sales
$536.77 million
Cash Flow
$2.16 per share
Book Value
$7.04 per share

Miscellaneous

Free Float
49,635,000
Market Cap
$4.78 billion
Optionable
Optionable
Beta
0.65

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

Key Executives

  • Dr. Catherine Ford Corrigan P.E. (Age 55)
    Ph.D., President, CEO & Director
    Comp: $1.67M
  • Mr. Richard L. Schlenker Jr.Mr. Richard L. Schlenker Jr. (Age 58)
    Executive VP, CFO & Corporate Secretary
    Comp: $1.09M
  • Dr. Maureen T. F. Reitman F.S.P.E. (Age 55)
    P.E., Sc.D., Group Vice President
    Comp: $1.11M
  • Dr. Eric Guyer P.E. (Age 47)
    Ph.D., Group Vice President
    Comp: $1.08M
  • Dr. Joseph Rakow Ph.D.
    Group Vice President
  • Dr. Bernard Ross P.E.
    Ph.D., Co-Founder, Chairman Emeritus & Principal Engineer
  • Dr. Subbaiah V. Malladi P.E. (Age 77)
    Ph.D., CTO & Principal Engineer
    Comp: $972k
  • Ms. Gina Flynn
    VP of Legal & General Counsel
  • Mr. Brian Kundert (Age 49)
    Chief Human Resources Officer
  • Mr. Eric R. Anderson
    VP, Corporate Controller & Treasurer

EXPO Stock Analysis - Frequently Asked Questions

How have EXPO shares performed this year?

Exponent's stock was trading at $88.04 at the beginning of the year. Since then, EXPO stock has increased by 7.1% and is now trading at $94.25.
View the best growth stocks for 2024 here
.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) announced its quarterly earnings results on Thursday, April, 25th. The business services provider reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.13. Exponent's revenue for the quarter was up 6.6% on a year-over-year basis.

When did Exponent's stock split?

Shares of Exponent split on the morning of Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly issued shares were issued to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What is Catherine Corrigan's approval rating as Exponent's CEO?

15 employees have rated Exponent Chief Executive Officer Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among the company's employees.

Does Exponent have any subsidiaries?

Exponent subsidiaries include these companies: Dennis Publishing.

Who are Exponent's major shareholders?

Exponent's top institutional shareholders include GAMMA Investing LLC. Insiders that own company stock include Paul R Johnston, Maureen T F Reitman, Steven J Murray, Sally Shepard, Harri Kytomaa, Richard Reiss, Carol Lindstrom, Eric Guyer, Bradley A James, Joseph Rakow and George H Brown.
View institutional ownership trends
.

How do I buy shares of Exponent?

Shares of EXPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Exponent own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU) and AT&T (T).

This page (NASDAQ:EXPO) was last updated on 7/8/2024 by MarketBeat.com Staff

From Our Partners